title: Metronomic cyclophosphamide and methotrexate for breast cancer: enhanced efficacy by adding dalteparin and low-dose prednisone?
authors: Robert
authors: R
authors: Buckman
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001365:Axilla; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage*; D017985:Dalteparin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008727:Methotrexate / Q000008:administration & dosage*; D009362:Neoplasm Metastasis; D011241:Prednisone / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed
chemical_list: D003520:Cyclophosphamide; D017985:Dalteparin; D011241:Prednisone; D008727:Methotrexate